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KEY FINDINGS– 2015 HIV DATA 
 
There were 485 HIV notifications in Ireland in 2015, giving a rate of 10.6 per 100,000 
population, the highest rate ever reported in Ireland. ECDC reported a rate of 5.9 per 100,000 
population in 2014 for countries in the European Union and European Economic Area 
(EU/EEA) (1). Between 2010 and 2014, HIV diagnosis rates in Ireland were stable but increased 
by 30% between 2014 and 2015. This increase was mainly confined to HSE East (where a 38% 
increase in rate was seen). A number of factors contributed to the increase in HSE East, 
including an improvement to the national surveillance case definition introduced in January 
2015 which resulted in improved sensitivity, timeliness and increased number of notifications; 
an outbreak of HIV among people who inject drugs (PWID) (2); and an increase in diagnoses 
among migrant men who have sex with men (MSM).  
 
Sex between men was the predominant route of HIV transmission in Ireland in 2015 and 
accounted for just over half of diagnoses, up from 49% in 2014. A high proportion (29%) were 
previously diagnosed positive abroad and 82% of these men had transferred their HIV care to 
Ireland. There was a large increase in the number of diagnoses in MSM between 2014 and 
2015, particularly among men from Latin America. Given this large increase, and also 
increases in other STIs among MSM, a national outbreak response group was established in 
early 2016 to address this evolving situation. This group is developing responses to the 
situation including: increasing promotion of safer sex messages and promoting regular HIV 
and STI testing through the man2man.ie programme; increasing testing capacity for MSM in 
Dublin via a new clinic, being piloted at the Gay Mens health Service;  and employing outreach 
workers on a pilot basis to deliver peer support and interventions among the MSM 
community, in particular among Latin American MSM.  
 
Diagnoses among PWID increased in 2015 due to an outbreak of recently acquired HIV among 
PWID living in Dublin (2). This occurred in homeless chaotic long term polydrug users. Among 
this population, the outbreak was associated with injection of snow blow, a new psychoactive 
substance, the re-use of needles and syringes, and having a sexual partner who was also 
injecting drugs (3). Prevention and control efforts were targeted to this group and the 
outbreak was declared over in February 2016. As a result of the outbreak, there was increased 
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testing among PWID and improved surveillance in this group.  However, there is a need for 
ongoing sustained health promotion and harm reduction activities among this very vulnerable 
group.  
 
Another significant change in 2015 was a big increase in the proportion of cases notified who 
had a previous HIV positive diagnosis abroad. This proportion was 27% in 2015, up from a 
range of 14-18% between 2011 and 2014. The majority of these people (79%) transferred 
their HIV care to Ireland. The change in case definition in January 2015 may account for some 
of the increase in this proportion, as those known to have been previously treated abroad, 
may not have two separate tests to confirm HIV diagnosis on arrival in Ireland, and would not 
have been included in surveillance prior to 2015, but are now included in the national figures. 
The increasing proportion of cases that are new to Ireland, but previously diagnosed abroad, 
has significant implications in relation to interpretation of the surveillance data, particularly in 
relation to late presentation and late diagnosis. This year, the data on late diagnosis are 
presented separately for all diagnoses and for diagnoses excluding those who were previously 
diagnosed abroad.  
 
Late diagnosis of HIV is an important public health issue in Ireland with 45% of all diagnoses in 
2015 classified as late.  Among those who were previously diagnosed HIV positive abroad, a 
lower proportion (31%) presented late. When those with a previous diagnosis abroad were 
excluded, the proportion diagnosed late was higher (52%), particularly among heterosexual 
males and those from sub-Saharan Africa. There is a need to further support access to, and 
uptake of HIV screening among these groups.  
 
Table 1 highlights the key findings from the 2015 HIV report. 
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Table 1: Characteristics of HIV diagnoses, 2015 
Number of HIV diagnoses 485 
Rate of diagnoses (per 100,000 population)1 10.6 
Gender Males (%) 76.1 
Females (%) 23.9 
Male to female ratio 3.2 
Age Median age of adult cases (years) 34 
Age range of adult cases (years) 18-72 
Young people aged 15-24 years (%) 8.0 
Aged 50 and older (%) 9.3 
Route of Transmission MSM (%) 50.9 
Heterosexual (%) 26.8 
Injecting Drug Use (%) 10.1 
Mother to Child transmission (%) 1.0 
Unknown (%) 11.1 
Region of Birth Born in Ireland (%) 29.9 
Born Abroad (%) 55.1 
Unknown (%) 15.1 
Co-infections Acute STI (%) 14.0 
TB (%) 1.2 
Hepatitis B (%) 2.5 
Hepatitis C (%) 8.5 
Previous history of testing Previously tested positive abroad (%) 26.6 
Transfer of care (of those previously 
positive abroad) 
79.1 
 
 
 
 
 
 
 
 
 
 
                                                                
1
 Based on 2011 census 
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1. HIV DIAGNOSES - 2015 
There were 485 new HIV diagnoses notified in Ireland in 2015, a crude notification rate of 10.6 
per 100,000 population2. Figure 1 shows the trend in the rate of HIV diagnoses and the 
diagnosis rate from 2003 to 2015. Between 2010 and 2014, the rate of diagnosis was fairly 
stable and between 2014 and 2015, there was a 30% increase in the rate (from 8.2 to 10.6 per 
100,000). However, the increase needs to be interpreted in light of a change in the case 
definition for surveillance which  was introduced in January 2015 in HSE East (Dublin, Kildare 
and Wicklow) which improved both the timeliness of notifications and resulted in an increase 
in the number of notifications (see technical note on page 30). 
 
Completed enhanced surveillance forms (ESFs) were received for 80% (n=380) of diagnoses in 
2015 (as of 2nd August 2016). 
 
Since the early 1980’s and to the end of 2015, 7,838 people have been newly diagnosed with 
HIV in Ireland.  However, this number does not represent the number of people living with 
HIV (PLHIV) in Ireland, as it does not take factors such as death and migration into account.  
 
Figure 1: HIV diagnoses and diagnosis rate (per 100,000), 2003 to 2015 
 
 
                                                                
2
 Based on 2011 census 
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1.1 GENDER AND AGE 
In 2015, 76% (n=369) of HIV diagnoses were in men and 24% (n=116) were in women, with a 
male to female ratio of 3.2. The median age of adult cases at HIV diagnosis was 34 years 
(range: 18 to 72 years); 34 years in men (range: 19-72 years) and 34 years in women (range: 
18 to 71 years).  
 
Table 2 shows the age breakdown of cases in males and females. The highest proportion 
(43%) was reported in 30-39 year olds. Eight percent of cases were in young people (15-24 
years of age) and 9% were in those aged 50 and older.  
 
Table 2: HIV diagnoses by age group and gender, 2015 
Age Group  
(years) 
Male Female Total 
N % N % N % 
<15 0 0.0 1 0.9 1 0.2 
15-19 2 0.5 4 3.4 6 1.2 
20-24  26 7.0 7 6.0 33 6.8 
25-29  72 19.5 23 19.8 95 19.6 
30-34 87 23.6 25 21.6 112 23.1 
35-39  67 18.2 28 24.1 95 19.6 
40-44 45 12.2 13 11.2 58 12.0 
45-49  35 9.5 5 4.3 40 8.2 
50+ 35 9.5 10 8.6 45 9.3 
Total 369 100.0 116 100.0 485 100.0 
 
 
The rate of diagnoses among men was 16 per 100,000 population compared to 5 per 100,000 
population among women. Figure 2 shows the age specific rates among men and women. 
Men had higher age-specific rates than women in all age groups, except in those aged 15-19 
years. The highest rate of diagnoses in men was in 30-34 year olds (45 per 100,000) and in 
women was in 35-39 year olds (16 per 100,000).   
 
Figure 3 describes the trends in rates of new HIV diagnoses in men and women from 2003 to 
2015. The rate among women halved between 2003 and 2015. The rate among men increased 
from 10.5 per 100,000 in 2003 to 16.2 per 100,000 in 2015, reflecting the large increase in the 
number of diagnoses among MSM.  
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Figure 2: Rate of HIV diagnoses (per 100,000 population) among males and females, 2015 
 
 
Figure 3: Trends in rate of HIV diagnoses by gender, 2003 to 2015 
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1.2 PROBABLE ROUTE OF TRANSMISSION 
Information on probable route of transmission was available for 89% (n=431) of diagnoses in 
2015. Sex between men remains the predominant mode of HIV transmission reported in 
Ireland, accounting for 51% (n=247) of HIV diagnoses in 2015. Heterosexual transmission is 
the second most commonly reported mode of transmission accounting for 27% (n=130) of HIV 
diagnoses. Ten percent (n=49) of diagnoses in 2015 were attributed to injecting drug use. 
There were five cases reported where the route of transmission was identified as mother to 
child transmission (MTCT). None of these cases were born in Ireland and there were no 
reported MTC transmissions in Ireland in 2015 (Personal communication; Michelle Goode, July 
2016).3 Further information on diagnoses in MSM, heterosexuals and PWID is available later in 
the report (pages 24-29).  
 
Table 3 details the 2015 diagnoses by probable route of transmission and gender. Sex 
between men was the commonest route among men and accounted for 67% of new 
diagnoses. Heterosexual transmission was the most common route among women and 
accounted for 68% of diagnoses.   
 
Table 3: HIV diagnoses by probable route of transmission and gender, 2015 
 Male Female Total 
MSM 247 66.9 - - 247 50.9 
Hetero 51 13.8 79 68.1 130 26.8 
PWID 37 10.0 12 10.3 49 10.1 
MTCT 2 0.5 3 2.6 5 1.0 
Unknown 32 8.7 22 19.0 54 11.1 
Total 369 100.0 116 100.0 485 100.0 
 
Figure 4 details the 2015 cases by probable route of transmission and age group. The 30-39 
year olds accounted for most HIV diagnoses in all transmission groups, including 55% of cases 
attributed to injecting drug use. Cases attributed to sex between men predominated in all age 
groups, over 20 years.  
                                                                
3
 The Rainbow Clinic in Our Lady’s Children’s Hospital in Crumlin reported that there were 90 babies born to HIV 
infected mothers in Ireland during 2015. At the time of this report, (based on serial HIV PCR testing); 86 of these 
infants are not infected and 4 remain of indeterminate status (i.e. do not meet the criteria for HIV infection and 
are <18 months at time of test). 
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Figure 4: HIV diagnoses by probable route of transmission and age group, 2015 
 
 
Table 4 and figure 5 show the trend in HIV diagnoses by route of transmission from 2003 to 
2015. In the 10 years since 2005, the number of diagnoses among MSM has increased four-
fold (from 60 to 247). The number of cases among heterosexuals has remained very stable 
since 2010 with between 125 and 132 cases per year. The number among PWID increased 
sharply in 2015 due to an outbreak of HIV among PWID (2,3).  
 
Table 4: HIV diagnoses by probable route of transmission, 2003 to 2015 
Probable 
route 
transmission 
MSM PWID Hetero MTCT Unknown Total 
 No.  % No.  % No.  % No.  % No.  %  
2003 76 19.0 50 12.5 222 55.4 11 2.7 42 10.5 401 
2004 63 17.6 74 20.7 179 50.0 3 0.8 39 10.9 358 
2005 60 18.4 67 20.6 171 52.5 3 0.9 25 7.7 326 
2006 89 25.2 59 16.7 181 51.3 2 0.6 22 6.2 353 
2007 91 23.3 55 14.1 165 42.2 6 1.5 74 18.9 391 
2008 105 26.0 40 9.9 190 47.0 7 1.7 62 15.3 404 
2009 138 34.9 30 7.6 162 41.0 5 1.3 60 15.2 395 
2010 134 40.6 23 7.0 127 38.5 9 2.7 37 11.2 330 
2011 145 44.5 17 5.2 125 38.3 3 0.9 36 11.0 326 
2012 166 48.8 16 4.7 132 38.8 5 1.5 21 6.2 340 
2013 158 46.3 21 6.2 131 38.4 3 0.9 28 8.2 341 
2014 183 48.5 27 7.2 125 33.2 2 0.5 40 10.6 377 
2015 247 50.9 49 10.1 130 26.8 5 1.0 54 11.1 485 
  
12 
 
 
 
 
Figure 5: Trend in HIV diagnoses by probable route of transmission, 2003 to 2015 
 
 
1.3 REGION OF BIRTH 
Of the diagnoses in 2015, 30% (n=145) were born in Ireland, 55% (n=267) were born abroad 
and 15% (n=73) did not have information on country of birth. Of the 267 cases among 
migrants, 35% (n=94) were born in sub-Saharan Africa and 33% (n=88) were born in Latin 
America.  
 
Table 5 shows the breakdown of diagnoses by region of birth and gender. Just over a third 
(35%) of the male cases were born in Ireland while only 15% of the female cases were born in 
Ireland. Over half (53%) of female cases were born in sub-Saharan Africa.   
 
Table 5: HIV diagnoses by region of birth and gender, 2015 
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Sub Saharan Africa 33 8.9 61 52.6 94 19.4 
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South and South East Asia 9 2.4 2 1.7 11 2.3 
North America 4 1.1 0 0.0 4 0.8 
Other 5 1.3 1 0.9 6 1.2 
Total 369 100.0 116 100.0 485 100.0 
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Geographic origin varied by route of transmission and figure 6 shows the proportion by 
geographic origin for each route of transmission. Just over a third (34%) of MSM were born in 
Latin America, 33% in Ireland and 17% in Europe. Fifty eight percent of heterosexual cases 
were born in sub-Saharan Africa and 24% were Irish born. Fifty-five percent of PWID were 
born in Ireland.  
 
Figure 6: HIV diagnoses by region of birth and probable route of transmission, 2015 
 
Figure 7 presents the trend in the rate4 of diagnoses among those who are born in Ireland and 
migrants5. The rate among those who are born in Ireland has stayed very stable since 2003, 
ranging from 3.4 to 4.2 per 100,000 population. There has been much greater fluctuation in 
the rate among migrants and the rate has increased from 18.4 in 2011 to 34.8 per 100,000 in 
2015.  
                                                                
4
 Rates should be interpreted with caution as intra-census year rates are calculated using population data from 
the census year (2002, 2006 and 2011). It is likely that there are ongoing changes in migrant populations in 
Ireland.  
5
 Not born in Ireland 
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Figure 7: Trend in HIV diagnoses by migrant status, 2003 to 2015 
 
 
1.4 AREA OF RESIDENCE 
The number of HIV diagnoses in each HSE area and the rate per 100,000 is shown in table 6. In 
2015, 359 new HIV cases were diagnosed in people living in HSE East, a rate of 22.2 per 
100,000 population. The rate is over twice the national rate. All other areas had rates lower 
than 6 per 100,000 with the lowest rates in HSE-Northwest (2.7) and HSE-Southeast (2.8).  
 
Figure 8 shows the rate6 of diagnoses in HSE areas from 2012 to 2015 (with 95% confidence 
intervals). There was a significant increase (38%) in the rate of diagnoses in HSE East between 
2014 and 2015, from 16.1 to 22.2 per 100,000 population. No other area had a significant 
change.  
 
 
 
 
 
 
 
                                                                
6
 Based on 2011 census 
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Table 6: Number and rate of HIV diagnoses by HSE area of residence7, 2015 
HSE Area Counties Number Rate per 100,000 
East Dublin, Kildare, Wicklow 359 22.2 
Midlands Laois, Longford, Offaly, Westmeath  13 4.6 
Midwest Limerick, Clare, Tipperary North 20 5.3 
Northeast Louth, Meath, Cavan, Monaghan  22 5.0 
Northwest Sligo, Leitrim, Donegal  7 2.7 
Southeast Wexford, Waterford, Carlow,  
Kilkenny, Tipperary South 
14 2.8 
South Cork, Kerry 34 5.1 
West Galway, Mayo, Roscommon 16 3.6 
Total  485 10.6 
 
 
Figure 8: Trend in the rate of HIV diagnoses by area of residence, 2003 to 2015 
 
 
1.5 PREVIOUSLY TESTED POSITIVE ABROAD INCLUDING TRANSFER OF CARE 
Notifications of HIV include all people who are diagnosed HIV positive for the first time in 
Ireland and include a number of people who have been previously diagnosed HIV positive 
abroad. Among the diagnoses in 2015, 27% (n=129) were reported to have previously tested 
HIV positive abroad. Of those who previously tested positive abroad, 64% had been on anti-
retroviral therapy (ART).  
 
                                                                
7
 If information on area of residence is not available, cases are assigned to the HSE area of the clinician or the 
laboratory. 
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Table 7 describes those who previously tested positive by probable route of transmission. 
Heterosexuals were the group with the highest proportion previously diagnosed HIV positive 
abroad (35%), followed by MSM (29%) and PWID (10%).  
 
Table 7: HIV diagnoses by history of previous HIV diagnosis abroad and probable route of 
transmission, 2015 
 MSM Hetero PWID Unknown Total 
Previously diagnosed HIV 
positive abroad 
72 29.1 45 34.6 5 10.2 7 11.9 129 26.6 
Not previously HIV 
positive/Not known 
175 70.9 85 65.4 44 89.8 52 88.1 356 73.4 
Total 247 100.0 130 100.0 49 100.0 59 100.0 485 100.0 
 
Figure 9 shows the trend in the number of people who were previously diagnosed HIV positive 
abroad from 2012 to 2015. The number with a previous HIV diagnosis abroad almost doubled 
between 2014 and 2015 (from 67 to 129). The change in case definition in January 2015 may 
account for some of the increase in this proportion, as those known to have been previously 
treated abroad, may not have had two separate tests to confirm HIV diagnosis on arrival in 
Ireland, and would not have been included in surveillance prior to 2015, but are now included 
in the national figures. However, there has also been an increase between 2014 and 2015 
(15%) among people who did not previously have a HIV diagnosis abroad (from 310 to 356).   
 
 
Figure 9: Trend in HIV diagnoses by history of previous positive diagnosis, 2012 to 2015 
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Figure 10 shows the trend in the proportion of people who were previously diagnosed HIV 
positive abroad from 2012 to 2015 by route of transmission. The proportion who were 
previously diagnosed HIV positive abroad was highest among heterosexuals from 2012 to 
2015 and increased from 23% in 2014 to 35% in 2015. The proportion among MSM increased 
from 17% in 2014 to 29% in 2015.  
 
 
Figure 10: Trend in proportion previously HIV positive by route of tranmission, 2012 to 2015 
 
Transfer of care 
Since 2015, data is collected on whether a person is a “transfer of care” (previously in care in 
another country and this care is transferred to a service in Ireland). One hundred and two 
people diagnosed in Ireland in 2015 were “transfer of care”. This represents 79% of those who 
were previously diagnosed HIV positive abroad and 21% of HIV diagnoses in 2015. Of the 102 
people, 73% were previously on ART, 12% were started on ART at this diagnosis, for 8% of 
cases ART was not indicated and for the remaining 8% the information was not available.  
 By risk group, 27% of heterosexuals, 24% of MSM and 8% of PWID were reported as 
transfer of care.  
 By region of birth, 35% of migrants and 5% of Irish born and were reported as transfer 
of care. 
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1.6 STAGE OF HIV INFECTION  
 
Late Diagnosis: CD4 count of less than 350 cells/µl at diagnosis or an AIDS defining illness at diagnosis (excluding 
those with evidence of acute infection
8
) 
Advanced HIV Infection: CD4 count of less than 200 cells/µl at diagnosis or an AIDS defining illness at diagnosis 
(excluding those with evidence of acute infection
8
) 
 
Late presentation  
Of all people diagnosed with HIV in Ireland in 2015, 45% were late presenters (where 
information on CD4 count or AIDS defining illness at diagnosis was available). This is slightly 
lower than the proportion in recent years (47% in 2014 and 49% in 2013). However, 
information on stage of diagnosis (CD4 count at diagnosis or AIDS defining illness) was only 
available for 74% of cases in 2015 which is considerably less than in 2014 (88%) and 2013 
(89%).  
 
Considering the high proportion of people diagnosed with HIV in Ireland who have previously 
been diagnosed HIV positive abroad, it is important to separate out these groups when 
looking at late presentation. The proportion of people who presented late was much lower 
(31%) among those who had a previous HIV diagnosis abroad compared to those who were 
not reported to have a previous diagnosis abroad (52%).  
 
Table 8 presents the proportion presenting late among (a) all diagnoses in 2015 and (b) among 
those who were not previously diagnosed HIV positive abroad. The groups with the highest 
proportions presenting late were male heterosexuals, people aged 50 years and over and 
people born in sub-Saharan Africa. 
 
 
 
 
 
                                                                
8
 P24 antigen positive or clinical diagnosis of acute sero-conversion illness 
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Table 8: Frequency of late presentation in all 2015 HIV diagnoses by gender, probable route 
of transmission, age group and region of origin, 2015  
 Number and Proportion presenting late9 10 
 All 2015 diagnoses 2015 diagnoses excluding 
those previously HIV 
positive abroad  
n % n % 
Total 161 45.1 126 51.9 
Gender Female 39 48.8 26 53.1 
Male 122 44.0 100 51.5 
Route of transmission MSM 71 35.9 55 42.0 
PWID 17 53.1 15 51.7 
Hetero- male 34 67.4 27 81.8 
Hetero - female 31 50.7 24 57.1 
Age Group (yrs) 20-29 44 41.9 33 45.2 
30-39 65 45.5 50 53.8 
40-49 31 46.3 27 55.1 
50+ 20 54.1 16 64.0 
Region of origin Ireland 58 45.0 55 47.8 
Europe 24 44.4 16 61.5 
Latin America 27 33.8 29 49.2 
Sub-Saharan Africa 41 56.2 28 68.3 
 
 
Advanced HIV Infection 
Of all people diagnosed with HIV in Ireland in 2015, 23% had advanced HIV infection (where 
information on CD4 count or AIDS defining illness at diagnosis was available). This compares 
to 27% in 2014 and 26% in 2013. 
 
The proportion of people who presented with advanced HIV infection was much lower (11%) 
among those who had a previous HIV diagnosis abroad compared to those who were not 
reported to have a previous diagnosis abroad (28%).  
 
 
 
                                                                
9
 Late defined as CD4 count less than 350 cells/µl at diagnosis or an AIDS defining illness at diagnosis 
10
 Where information on CD4 count or AIDS defining illness at diagnosis was available 
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1.7 CLINICAL STAGE AT DIAGNOSIS 
Clinicians are also asked to indicate the clinical stage at diagnosis for people newly diagnosed 
with HIV. Of the 2015 cases, 50% (n=240) were asymptomatic, 13% (n=61) were symptomatic 
(non-AIDS), 6% (n=29) had an AIDS-defining illness, 2% (n=9) had an acute sero-conversion 
illness, and the clinical stage was not reported for the remaining 30% (n=146).  
 
AIDS defining illness at time of HIV diagnosis  
Of the 29 people with an AIDS defining illness at the time of HIV diagnosis 
 Fourteen were heterosexual, 13 were MSM, one was a PWID and one did not have a 
reported risk group 
 Sixteen were born in Ireland and 13 were migrants.  
 The most commonly reported AIDS defining illnesses were PCP (Pneumocystis 
pneumonia) (34%) which was also the most common AIDS defining illness among MSM 
(39%) and heterosexuals (29%).  
 
1.8 CO-INFECTIONS 
Table 9 presents data on co-infections with acute infectious syphilis, chlamydia, gonorrhoea, 
TB, hepatitis B and C by probable route of transmission.11  
 
Co-infection with STIs 
People co-infected with HIV and sexually transmitted infections (STIs) are more likely to 
transmit HIV during sex (4). Of new HIV diagnoses in 2015, 14% were co-infected with an 
acute bacterial STI (chlamydia, gonorrhoea and/or early infectious syphilis). This was highest 
among MSM with 23% having a concurrent bacterial STI, compared to 5% among 
heterosexuals and 4% among PWID. 
 
Co-infection with TB  
Six people (1%) were co-infected with TB at the time of HIV diagnosis.  
 
 
                                                                
11
 Data on co-infections are obtained from data provided on the HIV enhanced surveillance form. 
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Co-infection with Hepatitis B and C 
Twelve people (3%) were co-infected with hepatitis B, including one person co-infected with 
acute hepatitis B. Forty one people (9%) were co-infected with hepatitis C, including two 
people with acute hepatitis C.  
 
Table 9: Co-infections with HIV by probable route of transmission, 2015 
 MSM Hetero PWID Total 
Co-infection with  No.  %  No.  % No. % No.  % 
Acute STI12 57 23.1 7 5.4 2 4.1 68 14.0 
Chlamydia 23 9.3 4 3.1 0 0 27 5.6 
Gonorrhoea 25 10.1 0 0.0 0 0 25 5.2 
Early Infectious Syphilis 20 8.1 4 3.1 2 4.1 28 5.8 
TB 1 0.4 4 3.1 1 2.0 6 1.2 
Hepatitis B  1 0.4 6 4.6 3 6.1 12 2.5 
Hepatitis C 3 1.2 5 3.8 31 63.3 41 8.5 
 
 
1.9 HISTORY OF HIV TESTING  
Of diagnoses in 2015, 36% reported having previously tested negative, 23% reported that they 
did not have a previous negative test and information was unavailable for the remaining 41%.  
 
Table 10 describes HIV testing history by probable route of transmission. The proportion with 
a history of a previous negative HIV test was highest among PWID (57%) followed by MSM 
(45%) and heterosexuals (27%). The proportion who were infected in either 2014 or 2015 (had 
a previous negative test in either 2014 or 2015) was highest among PWID (23%), followed by 
MSM (20%) and lowest among heterosexuals (3%). 
 
Table 10: HIV diagnoses by probable route of transmission and HIV testing history, 2015 
 MSM Hetero PWID Other/Unk Total 
 No % No % No % No % No % 
Previous negative test 
in 2014/2015 
50 20.2 4 3.1 11 22.5 2 3.4 67 13.8 
Previous negative test 
pre 2014 
60 24.3 31 23.8 17 34.7 1 1.7 109 22.5 
No previous negative 
test 
54 21.9 42 32.3 5 10.2 9 15.3 110 22.7 
Unknown 83 33.6 53 40.8 16 32.7 47 79.7 199 41.0 
Total 247 100.0 130 100.0 49 100.0 59 100.0 485 100.0 
                                                                
12
 Acute STI: chlamydia, gonorrhoea or early infectious syphilis 
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2. LABORATORY DATA 
2.1 HIV RESISTANCE DATA 
Transmitted (or primary) HIV drug resistance (TDR) occurs when a resistant virus is acquired 
by a treatment naïve individual.  TDR is of public health concern as it has implications for 
national treatment policies and first line treatment options. 
 
At present, the NVRL performs genotypic antiretroviral resistance testing (GART) primarily for 
clinical purposes. During 2015, GART was performed by the NVRL on 293 samples from 
individuals newly diagnosed with HIV13. Amongst these, one or more resistance mutations, 
from the 2009 World Health Organization (WHO) list of surveillance drug resistant mutations 
(SDRMs) (5), was detected in 20 presumed treatment naïve individuals, yielding a TDR rate of 
6.8%. This is in keeping with previously published findings from the period 2004 through 2008 
(6). Twenty eight SDRMs were detected in these 20 individuals: 16 non-nucleoside reverse 
transcriptase inhibitors (NNRTI); eight nucleoside reverse transcriptase inhibitors (NRTI); and 
four protease inhibitors (PI). Seventeen individuals had resistance to a single drug class, two 
had dual class resistance, and one had resistance to three drug classes. Mutations detected 
are outlined in appendix 2.  
 
Given its potential impact on the control of HIV, WHO and ECDC recommend the surveillance 
of TDR. The establishment of national TDR surveillance is currently being considered.  
 
2.2 HIV TESTING DATA 
In 2015, there were 178,267 HIV tests carried out in 12 laboratories in Ireland14, 110,602 tests 
among females and 66,904 tests among males (761 gender unknown). This gives a testing rate 
of 38.9 per 1,000 population (47.8 per 1,000 among females and 29.4 per 1,000 among 
males). The higher rate of testing in females reflects the HIV antenatal screening programme. 
                                                                
13
 Not all newly diagnosed samples underwent GART due to non-receipt of a sample or clinical request, or due to 
an undetectable viral load. 
 
14
 Hospitals which provided 2015 HIV testing data: Biomnis Laboratory, Dublin; Bon Secours, Cork; Galway Clinic; 
Galway University Hospital; Mercy University Hospital, Cork; Limerick University Hospital; National Virus 
Reference Laboratory, Dublin;  Portiuncula Hospital, Galway; Rotunda Maternity Hospital, Dublin; Galway 
University Hospital; St James's Hospital, Dublin; Waterford Regional Hospital; Sligo Regional Hospital 
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It is important to note that the calculated testing rate are likely to over-estimate the true rate 
of testing in the population as the numbers reported are not of individuals who have been 
tested but of tests performed and can include repeat tests on the same individual.  
 
3. DEATHS DUE TO HIV AND AIDS IN 2015 
Data on deaths are obtained from (a) clinicians reports via the enhanced surveillance form 
and (b) data reported to the CSO. It is not possible to link the two sources of information.  
 
Data from enhanced surveillance forms 
Among the HIV diagnoses in 2015, six people were reported to have died at the time of HIV 
notification. The deaths were in five men and one woman. The route of transmission for the 
people who died was injecting drug use (n=3), heterosexual transmission (n=1), sex between 
men (n=1) and unknown (n=1). 
 
Data from CSO Vital Statistics report  
There were nine deaths reported to the CSO in 2015 where the cause of death was AIDS or 
HIV, eight males and one female (see Table 11).  
 
Table 11: Number of deaths reported to CSO in 2015 where cause of death is AIDS or HIV15 
  Age Group (years) 
 15-24 25-34 35-44 45-54 55+ Total 
Male 0 1 1 4 2 8 
Female 0 0 0 0 1 1 
Total 0 1 1 4 3 9 
 
 
 
 
 
                                                                
15
 Source: Vital Statistics Reports, CSO available at  
http://www.cso.ie/en/releasesandpublications/ep/p-vsys/vitalstatisticsyearlysummary2015/  
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4. MEN WHO HAVE SEX WITH MEN (MSM) 
MSM remain the population most affected by HIV in Ireland. In 2015, there were 247 new HIV 
diagnoses reported among MSM which was just over half (51%) of all diagnoses in 2015. Table 
12 presents key characteristics of diagnoses among MSM in 2015. Of note, 29% of MSM 
diagnosed with HIV in Ireland in 2015 had a previous HIV diagnosis abroad and 82% of these 
men had transferred their HIV care from abroad to Ireland. 
 
The number of diagnoses in 2015 is the highest number ever reported among MSM in Ireland 
and is an increase of 34% compared to 2014. This is largely due to an increase in the number 
of diagnoses among MSM from Latin America (see Figure 11).  Forty percent of the diagnoses 
among MSM born in Latin America previously tested HIV positive abroad.  
 
By age group, the number of diagnoses among MSM has increased sharply among those aged 
25-39 years while the number in younger and older age groups have remained more stable 
(see Figure 12).  
 
Table 12: Characteristics of HIV diagnoses among MSM, 2015 
Age Median age (years) 32 
Age range of adult cases (years) 19-72 
Young people aged 15-24 years (%) 8.9 
Aged 50 and older (%) 8.5 
Geographic origin Born in Ireland (%) 32.8 
Born Abroad (%) 57.1 
Unknown (%) 10.1 
Stage of Infection 16 
(of those with CD4 count at diagnosis 
reported) 
Late (<350 cells/µl) (%) 35.9 
Advanced HIV infection (<200 cells/µl) (%) 15.7 
Concurrent AIDS diagnosis (%) 5.3 
Co-infections Acute STI (%) 23.1 
Gonorrhoea 10.1 
Chlamydia 9.3 
Early Infectious Syphilis 8.1 
Previous history of testing Previously tested positive abroad (%) 28.7 
Transfer of care (of those with a previous 
positive diagnosis) (%) 
81.9 
                                                                
16
 Stage of infection of all HIV diagnoses among MSM in 2015 (see Table 8 on page 19 for analysis among those 
without a previous positive diagnosis) 
  
25 
 
 
 
Figure 11: Trend in HIV diagnoses among MSM by region of birth, 2003 to 2015 
 
 
Figure 12: Trend in HIV diagnoses among MSM by age group, 2003 to 2015 
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5. HETEROSEXUALS 
Heterosexual transmission accounted for 27% of HIV diagnoses in Ireland in 2015, with 79 
diagnoses among females and 51 among males. Heterosexual contact is the most common 
HIV transmission method among women and the second most common among men in 
Ireland. Since 2010, the number of diagnoses among heterosexuals has remained fairly stable 
between 125 and 132 cases.  
 
Table 13 presents key characteristics of diagnoses among male and female heterosexuals in 
2015. Of note, 35% of heterosexual cases were previously diagnosed HIV positive abroad and 
78% of these people transferred their care to Ireland.  
 
Table 13: Characteristics of HIV diagnoses among male and female heterosexuals, 2015 
 Male Female 
Age Median age (years) 41 33 
Age range (years) 24-67 18-71 
Young people aged 15-24 years (%) 2.0 8.9 
Aged 50 and older (%) 13.7 12.7 
Geographic origin Ireland (%) 43.1 11.4 
Sub-Saharan Africa (%) 39.2 69.6 
Other (%) 13.9 11.8 
Unknown (%) 2.0 3.8 
Stage of Infection17 
(of those with CD4 count 
at diagnosis reported) 
Late (<350 cells/µl) (%) 67.4 50.0 
Advanced HIV infection (<200 cells/µl) (%) 45.7 23.9 
Concurrent AIDS diagnosis (%) 15.7 7.6 
Co-infections Acute STI (%) 5.9 5.1 
TB (%) 3.9 2.5 
Previous history of 
testing 
Previously tested positive abroad (%) 29.4 36.7 
Transfer of care (of those with a previous 
positive diagnosis abroad) (%) 
86.7 73.3 
Heterosexual 
subcategory 
Born in a county with a generalised epidemic 39.2 70.9 
Other18 13.7 8.9 
No risk identified 47.1 20.3 
 
                                                                
17
 Stage of infection of all HIV diagnoses in heterosexuals in 2015 (see Table 8 on page 19 for analysis among 
those without a previous positive diagnosis) 
18
 Other includes sexual partner from a country with a generalised epidemic, sexual partner who is high risk, 
sexual partner who is known to be HIV positive 
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The majority of heterosexual cases diagnosed in 2015 were born in sub-Saharan Africa, an 
area of the world which has a generalised HIV epidemic (>1% of the general population with 
HIV). Figure 13 shows the trend from 2003 to 2015 in the number of diagnoses among those 
born in sub-Saharan Africa and all other heterosexual cases.  
 
 
Figure 13: Trend in HIV diagnoses by heterosexual subcategory, 2003 to 2015 
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6. PEOPLE WHO INJECT DRUGS (PWID) 
Ten percent (n=49) of diagnoses in 2015 were among PWID. This was an increase of 81% 
compared to 2014 (n=27). This increase was due to an outbreak of recently acquired HIV 
infection among PWID living in Dublin in 2014/2015 (2,3). This occurred in generally homeless 
chaotic polydrug users, and among this population, the outbreak was associated with injection 
of snow blow, a synthetic cathinone. Other risk factors were found to be the re-use of needles 
and syringes and having a sexual partner who was also with injecting drugs. Prevention and 
control efforts were targeted to this group and the outbreak was declared over in February 
2016. As a result of the outbreak, there was increased testing among PWID and improved 
surveillance in this group.  
 
Table 14 presents key characteristics of diagnoses among PWID in 2015 and Figure 14 
describes the changing trend in male and female cases between 2003 and 2014.  
 
Table 14: Characteristics of HIV diagnoses among PWID, 2015 
Gender Males (%) 75.5 
Females (%) 24.5 
Male to female ratio 3.1 
Age Median age of adult cases (years) 37 
Age range of adult cases (years) 20-55 
Young people aged 15-24 years (%) 4.1 
Aged 50 and older (%) 6.1 
Geographic origin Born in Ireland (%) 55.1 
Born Abroad (%) 20.4 
Unknown (%) 24.5 
Stage of Infection19 
(of those with CD4 count at 
diagnosis reported) 
Late (<350 cells/µl) (%) 53.1 
Advanced HIV infection (<200 cells/µl) (%) 28.1 
Concurrent AIDS diagnosis (%) 
P24 Antigen Positve (indicating acute 
infection) 
0.0 
16.3 
Co-infections Hepatitis C (%) 53.1 
 Previous history of testing Previously tested positive abroad (%) 10.2 
 
 
 
 
                                                                
19
 Stage of infection of all HIV diagnoses in PWID in 2015 (see Table 8 on page 19 for analysis among those 
without a previous positive diagnosis) 
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Figure 14: Trend in HIV diagnoses among PWID by gender, 2003 to 2015 
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TECHNICAL NOTES 
 In January 2015, there was a change to the surveillance case definition for HIV for HSE 
East (Dublin, Kildare and Wicklow). Previously, confirmatory testing by the NVRL was 
required on two separate samples prior to notification. From January 2015 onwards, 
confirmatory testing by NVRL on one sample was sufficient prior to notification. This 
change was applied to notifications from all other HSE areas in January 2016. Further 
information on HIV surveillance in Ireland can be found at  
http://www.hpsc.ie/A-
Z/HIVSTIs/HIVandAIDS/SurveillanceDocuments/File,13903,en.pdf.  
 Data for this report were extracted from CIDR on 2nd August 2016 and were correct at 
the time of publication.  
 Data from previous years is updated on an ongoing basis in CIDR, and so data from 
previous years presented in this report represents our current understanding and most 
up to date data, and may not correspond exactly with what was reported in previous 
annual reports.  Similarly, data for 2015 may be updated further in due course and will 
be reported on in subsequent annual reports 
 Percentages are rounded up in the text and are provided to one decimal place in the 
tables. 
 For the purposes of this report, “Mother to Child Transmission” cases were included in 
the category “Unk/Other” for many of the tables and figures.   
 Data are presented by date of notification 
 
OTHER SOURCES OF DATA  
 Weekly, quarterly and annual reports on the epidemiology of HIV in Ireland can be found at  
http://www.hpsc.ie/A-Z/HIVSTIs/HIVandAIDS/SurveillanceReports/  
 Reports on HIV antenatal screening can be found at 
http://www.hpsc.ie/A-
Z/HIVSTIs/HIVandAIDS/AntenatalHIVTesting/ReportsonAntenatalHIVTestinginIreland/   
 The case definition for HIV can be found on the HPSC website at 
http://www.hpsc.ie/NotifiableDiseases/CaseDefinitions/  
 The HIV enhanced surveillance form can be found at  
http://www.hpsc.ie/A-Z/HIVSTIs/HIVandAIDS/SurveillanceDocuments/Surveillanceforms/  
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APPENDIX 1: ADDITIONAL TABLES 
 
Table A1:  HIV diagnoses by route of transmission and probable region of infection, 2015 
Probable region of 
Infection 
MSM Hetero PWID Other/Unk Total 
No.  % No.  % No.  % No.  % No.  % 
Ireland 107 43.3 36 27.7 27 55.1 4 6.8 174 35.9 
Sub-Saharan Africa 5 2.0 55 42.3 1 2.0 4 6.8 65 13.4 
Western Europe 26 10.5 5 3.8 0 0.0 0 0.0 31 6.4 
Central & Eastern Europe 6 2.4 6 4.6 4 8.2 3 5.1 19 3.9 
Latin America 48 19.4 1 0.8 0 0.0 0 0.0 49 10.1 
Other 11 4.5 4 3.1 1 2.0 5 8.5 21 4.3 
Unknown 44 17.8 23 17.7 16 32.7 43 72.9 126 26.0 
Total 247 100.0 130 100.0 49 100.0 59 100.0 485 100.0 
 
 
Table A2: HIV diagnoses by reason for HIV test, gender and route of transmission, 2015 
 Gender Probable route of transmission  
Reason for Test Female Male MSM Hetero PWID Oth/Unk Total 
Antenatal 18 - - 13 1 4 18 
Asylum seeker screening 11 9 2 16 2 - 20 
Known positive partner 5 26 17 12 2 - 31 
STI screen 7 91 80 14 3 1 98 
Risky behaviour 4 63 52 4 10 1 67 
Symptomatic 21 74 43 36 10 6 95 
Other 10 19 7 10 5 7 29 
Unknown 40 87 46 25 16 40 127 
Total 116 369 247 130 49 59 485 
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APPENDIX 1:  RESISTANCE MUTATIONS DETECTED IN IRELAND DURING 201520  
NRTI DRMs Frequency in 
Ireland 2015 
NNRTI DRMs Frequency in 
Ireland 2015 
PI DRMs Frequency in 
Ireland 2015 
M41L 3 L100I 1 L23I - 
K65R - K101E/P 1 L24I - 
D67N/G/E 1 K103N/S 9 D30N 1 
T69D/Ins - V106M/A - V32I - 
K70R/E 1 V179F - M46I/L 2 
L74V/I - Y181C/I/V - I47V/A - 
V75M/T/A/S - Y188L/H/C 1 G48V/M - 
F77L - G190A/S/E - I50V/L - 
Y115F - P225H 4 F53L/Y - 
F116Y - M230L - I54V/L/M/A/T/S - 
Q151M -   G73S/T/C/A - 
M184V 1   L76V - 
L210W -   V82A/T/F/S/C/M/L - 
T215Y/F/I/S 1   N83D - 
T215C/D/V/E 1   I84V/A/C - 
K219Q/E/N/R -   I85V - 
    N88D/S 1 
    L90M - 
TOTAL 8  16  4 
 
 
 
                                                                
20
 from the World Health Organisation 2009 List of Mutations for Surveillance of Transmitted Drug 
Resistance 
